Hepa-Merz Granulate Malta - English - Medicines Authority

hepa-merz granulate

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - l, ornithine, aspartate - granules for oral solution - l-ornithine 3 g/5g l-aspartate 3 g/5g - bile and liver therapy

Hepa-Merz infusion concentrate 0.5g/ml Malta - English - Medicines Authority

hepa-merz infusion concentrate 0.5g/ml

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - l, ornithine, aspartate - concentrate for solution for infusion - l-ornithine 5 g/ml l-aspartate 5 g/ml - bile and liver therapy

HepaMerz Granules Powder For Oral Solution Kenya - English - Pharmacy and Poisons Board

hepamerz granules powder for oral solution

win medicare private limited 1400 modi tower 98 nehru place delhi-110019 india. - l-ornithine-l-aspartate - powder for oral solution - each 5g sachet contains: l-ornithine-l-aspartate:… - liver therapy lipotropics

VANIQA- eflornithine hydrochloride cream United States - English - NLM (National Library of Medicine)

vaniqa- eflornithine hydrochloride cream

physicians total care, inc. - eflornithine hydrochloride (unii: 4nh22ndw9h) (eflornithine - unii:zqn1g5v6sr) - eflornithine hydrochloride anhydrous 139 mg in 1 g - vaniqa (eflornithine hydrochloride) cream, 13.9% is indicated for the reduction of unwanted facial hair in women. vaniqa has only been studied on the face and adjacent involved areas under the chin of affected individuals. usage should be limited to these areas of involvement. vaniqa is contraindicated in patients with a history of sensitivity to any components of the preparation.

VANIQA- eflornithine hydrochloride cream United States - English - NLM (National Library of Medicine)

vaniqa- eflornithine hydrochloride cream

allergan, inc. - eflornithine hydrochloride (unii: 4nh22ndw9h) (eflornithine - unii:zqn1g5v6sr) - eflornithine hydrochloride anhydrous 139 mg in 1 g - vaniqa ®   (eflornithine hydrochloride) cream, 13.9% is indicated for the reduction of unwanted facial hair in women. vaniqa ® has only been studied on the face and adjacent involved areas under the chin of affected individuals. usage should be limited to these areas of involvement. vaniqa ® is contraindicated in patients with a history of sensitivity to any components of the preparation.

VANIQA Israel - English - Ministry of Health

vaniqa

medison pharma ltd - eflornithine as hydrochloride monohydrate - cream - eflornithine as hydrochloride monohydrate 11.5 %w/w - eflornithine - eflornithine - vaniqa is indicated for the reduction of unwanted facial hair in women.

HEPA-MERZ INFUSION CONCENTRATE 5G10 ML Singapore - English - HSA (Health Sciences Authority)

hepa-merz infusion concentrate 5g10 ml

arqon pte. ltd. - l-ornithine-l-aspartate - infusion, solution concentrate - l-ornithine-l-aspartate 5g